June 2018: demonstrated that regular usage of our tablet formula significantly increased cardiorespiratory endurance (VO2max), time to exhaustion, and total work completed during an incremental exercise.
Feb 2019: demonstrated that aerobic exercise performance in young healthy participants was improved by significantly lowering the respiratory rate and heart rate by an average of five bpm
April 2019: demonstrated that 28 days of H2 supplementation clinically reduced liver fat in non alcoholic fatty liver disease and increased insulin sensitivity by 11%
July 2019: Case study demonstrated reduction of presence and severity of symptoms of sport-related mild traumatic brain injury (TBI).
March 2020: H2 water significantly reduced blood cholesterol and glucose levels, attenuated serum hemoglobin A1c, improved biomarkers of inflammation and redox homeostasis, and tended to promote a mild reduction in body mass index and waist-to-hip ratio.
If you are interested in the science on molecular hydrogen generally, please visit the Molecular Hydrogen Institute (MHI), which is dedicated to advancing the research, education, and awareness of hydrogen as a medical gas. The HydroTab product is not intended to treat any of the conditions mentioned in these molecular hydrogen studies, nor is there any evidence that the HydroTab product will provide any benefit to people with these conditions. molecularhydrogeninstitute.org
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.